Cargando…

Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer

IMPORTANCE: In 2020, some health insurance plans updated their medical policy to cover germline genetic testing for all patients diagnosed with colorectal cancer (CRC). Guidelines for universal tumor screening via microsatellite instability and/or immunohistochemistry (MSI/IHC) for mismatch repair p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moretz, Chad, Byfield, Stacey DaCosta, Hatchell, Kathryn E., Dalton, Joline, Onglao, Peter Nicholas, Hang, Lillian, Hansen, Pamela, Radford, Cristi, Nielsen, Sarah M., Heald, Brandie, Munro, Sandra B., Nussbaum, Robert L., Esplin, Edward D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593236/ https://www.ncbi.nlm.nih.gov/pubmed/36279135 http://dx.doi.org/10.1001/jamanetworkopen.2022.38167

Ejemplares similares

Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
por: Coughlin, Sarah E., et al.
Publicado: (2022)

Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making
por: Shelton, Charles, et al.
Publicado: (2023)

Rate of Pathogenic Germline Variants in Patients With Lung Cancer
por: Sorscher, Steven, et al.
Publicado: (2023)

The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
por: Schmidlen, Tara J., et al.
Publicado: (2022)

Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer
por: Lincoln, Stephen E., et al.
Publicado: (2020)

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer
por: Whitworth, Pat W., et al.
Publicado: (2022)

Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers
por: Forkosh, Esther, et al.
Publicado: (2022)

Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the Mark
por: Muller, Charles, et al.
Publicado: (2021)

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
por: Esplin, Edward D., et al.
Publicado: (2022)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study
por: Klek, Stefan, et al.
Publicado: (2020)

Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
por: Dellefave-Castillo, Lisa M., et al.
Publicado: (2022)

Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program
por: Jones, Jeremy C, et al.
Publicado: (2023)

Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo‐ECAG) ovarian study
por: Abdel‐Razeq, Hikmat, et al.
Publicado: (2022)

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study
por: Uson, P. L. S., et al.
Publicado: (2022)

Age distribution of patients with advanced non-melanoma skin cancer in the United States
por: Dacosta Byfield, Stacey, et al.
Publicado: (2013)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
por: Uson Junior, Pedro LS, et al.
Publicado: (2022)

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study
por: Uson, Pedro L. S., et al.
Publicado: (2021)

A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US
por: Villalobos, Victor M., et al.
Publicado: (2017)

A retrospective analysis of delays in the diagnosis of lung cancer and associated costs
por: Gildea, Thomas R, et al.
Publicado: (2017)

Comparison of family health history to personal genomic screening for risk assessment of colon cancer
por: Heald, Brandie, et al.
Publicado: (2011)

Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States
por: Dacosta Byfield, Stacey A., et al.
Publicado: (2019)

Germline testing and genetic counselling in prostate cancer
por: Russo, Jessica, et al.
Publicado: (2022)

Germline variant testing in serrated polyposis syndrome
por: Murphy, Aisling, et al.
Publicado: (2022)

An automated and objective cover test to measure heterophoria
por: Mestre, Clara, et al.
Publicado: (2018)

Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing
por: Vlessis, Katherine, et al.
Publicado: (2019)

Gastrointestinal polyposis and PTEN mutations: an under-acknowledged diagnostic criterion
por: Heald, Brandie, et al.
Publicado: (2010)

The Molecular Anatomy of Spontaneous Germline Mutations in Human Testes
por: Qin, Jian, et al.
Publicado: (2007)

Population based germline testing for primary cancer prevention
por: Manchanda, Ranjit, et al.
Publicado: (2018)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Variance components affecting the repeatability of the alternating cover test
por: Paulus, Marius M., et al.
Publicado: (2019)

Do Judge a Test by its Cover: Combining Combinatorial and Property-Based Testing
por: Goldstein, Harrison, et al.
Publicado: (2021)

Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions
por: Gal, Dana B., et al.
Publicado: (2021)

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021)

BRCA germline mutation test for all woman with ovarian cancer?
por: Paradiso, A. V., et al.
Publicado: (2019)

Disparities in germline testing among racial minorities with prostate cancer
por: Weise, Nicole, et al.
Publicado: (2021)

Discrepancies between tumor genomic profiling and germline genetic testing
por: Pauley, K., et al.
Publicado: (2022)

Prevalence of pathogenic germline variants in the circulating tumor DNA testing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2022)

Eligibility, uptake and response to germline genetic testing in women with DCIS
por: Turza, Lauren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tsvu1vci3b35norbdran749goe